CD8A and neoplasm: In vivo, transfection of B7-H3 into P815 mouse tumors led to tumor regression and amplification of tumor-specific CD8+ CTL response in syngeneic mice suggesting enhancement of tumor immunogenicity by preferential stimulation of CD8+ T cell responses [19].